This is not an official program of the American College of Rheumatology.
Tuesday, October 28, 2025
5:15 PM – 5:30 PM CT: Registration/Dinner
5:30 PM – 7:00 PM CT: CE Symposium
Marriott Marquis Chicago
2121 South Prairie Avenue
Chicago, IL 60616
Meeting Room: Jackson Park (First Floor)
PROGRAM FEATURES
- Interactive case-based presentation
- Downloadable whiteboard animations
- Online personalized quality-improvement poster-generation portal
PRESENTING FACULTY
 |
Matthew C. Baker MD, MS. Associate Division Chief Assistant Professor of Medicine Division of Immunology and Rheumatology Stanford University Stanford, California |
 |
John H. Stone, MD, MPH Professor of Medicine Harvard Medical School The Edward A. Fox Chair in Medicine Massachusetts General Hospital Executive Chairman, IgG4ward! Foundation Boston, Massachusetts |
PROGRAM OVERVIEW
In this interactive, case-based presentation, faculty will assess the severity of IgG4-related disease (IgG4-RD) by exploring its varied clinical manifestations. The session will highlight the latest diagnostic and classification criteria to enable earlier identification of IgG4-RD. Additionally, faculty will review clinical trial data on current and emerging therapies to guide evidence-based treatment decisions.
LEARNING OBJECTIVES
- Evaluate the severity of IgG4-related disease (IgG4-RD) by considering its diverse clinical presentations
- Apply the latest diagnostic and classification criteria for IgG4-RD to accurately assess disease activity and enhance diagnostic precision
- Analyze clinical trial data on current and emerging therapies to inform treatment decisions for IgG4-RD
TARGET AUDIENCE
This activity is designed to meet the educational needs of rheumatologists and their associated advanced practice providers (APPs, e.g., nurse practitioners and physician assistants) involved in the evaluation and management of patients with IgG4-RD.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.50 ANCC contact hours.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to the live event at [email protected]
